Last reviewed · How we verify
Patrol
At a glance
| Generic name | Patrol |
|---|---|
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Autonomous Navigating Robot for Detecting Falls and Risk of Falls in Nursing Home Residents With Alzheimer Disease/ADRD - Feasibility Study
- Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population
- Malnutrition Screening by Muscle Ultrasound in Patients Requiring Mechanical Ventilation in Intensive Care Unit (NA)
- The Effect of a Safety Video on Ski and Snowboard School Program Participants in Calgary, Alberta (NA)
- Levobupivacaine Prolonged Wound Infusion for Postoperative Pain Relief After Breast Surgery (PHASE4)
- Influence of the Education in Layperson in Out of Hospital Resuscitation
- Assessment and Prevention of Acute Post-herniotomy Pain (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Patrol CI brief — competitive landscape report
- Patrol updates RSS · CI watch RSS
- Fondazione IRCCS Policlinico San Matteo di Pavia portfolio CI